A study published in Clinical Cancer Research has revealed new insights into why…
Although artificial intelligence (AI) is helping to deliver earlier and better diagnoses of…
In patients with incidental pituitary microadenomas, two-thirds of the microadenomas…
A new radiopharmaceutical compound may be a viable treatment option for patients with…
The US FDA has cleared Elekta’s Comprehensive Motion Management (CMM) with True…
Recent increases in Medicare spending on outpatient cancer care at the end of…
Bladder cancer patients’ chance of staying cancer-free increases if they receive…
The February issue of The Journal of Nuclear Medicine (JNM) includes a new procedure…
A pivotal Phase III study for Telix Pharmaceuticals Limited’s TLX250-CDx demonstrated…
Blue Earth Diagnostics today announced additional results from its Phase 3 LIGHTHOUSE trial…
